Your address will show here +12 34 56 78
The New Path to Patient-Driven
Treatments and Cures

An increasingly connected world demands an equally connected system for medical solutions.
Overview
Whether it’s as simple as securely accessing patient health records from anywhere in the world or finding the best treatments that the world has to offer, it’s clear that patients, doctors, and innovators need a streamlined process to work, create, and treat seamlessly from anywhere in the world. Now more than ever, we need to accelerate the pace of innovation to develop new solutions to these growing healthcare challenges.

As the need for innovation grows, progress in the health sector too often slowed by inadequate funding and hampered by inefficiencies. This global urgency demands a radical shift in strategy, requiring massive capital inputs to drive the health system forward.
Empowering Patients
WITH THE FREEDOM TO CHOOSE
Patients are empowered when they can take an active role in their management of health and become stakeholders in the technologies that drive it. Acting as a bridge between patients and innovators creating tomorrow’s next breakthrough, Aevolve is able to provide patients with the industry’s cutting-edge innovations at the moment it becomes possible for the patient to receive it. Aevolve’s platform gives patients the ability to stand first in line alongside the innovators changing medicine as we know it and become part of a historic moment.
Supporting Innovators
INDEPENDENT BIOTECH COMPANIES
Where previously, independent biotech innovators would find great difficulty competing with their massive rivals, they can now receive the support they need to grow and reach market availability, while never sacrificing science in favor of business growth. Aevolve is facilitating the next wave of life-changing technologies by allowing the patients who will eventually receive the treatments to be stakeholders in the technologies they’re depending on.
New Exposure
NEXT GENERATION INVESTMENT PRODUCTS
Investment in blockchain technologies and cryptocurrency remains niche around the world due to poor public image and regulatory uncertainty. However, AVEX.AI represents the next generation of digital assets as it combines the promise and innovation of cryptocurrency, with the security and confidence of a traditional asset in the form of a classic tracker certificate on the Swiss Stock Exchange (The Six).
A New Channel
BRIDGING STAKEHOLDERS IN THE HEALTH INDUSTRY
Aevolve’s model allows more equitable participation and representation among investors, innovators and patients. It is a channel for greater communication among stakeholders in the health industry. Most of all, it allows patients to take charge of their own health decisions, with the aid and support of a global community.
Preservation of Equity
MORE VALUE. MORE LEVERAGE.
Aevolve allows innovators more diversified sources of capital and opportunities accelerate value.  These new abilities delivers leverage and opens ways to preserve ownership and reach their innovation goals.
THE NEW PATH TO PATIENT-DRIVEN TREATMENTS AND CURES
About Aevolve

Aevolve is a protocol that supports medical innovations from R&D stages to full-scale commercialization, by connecting patients, investors, and scientific innovators.

INVESTOR ACCESS TO A BILLION-DOLLAR ECOSYSTEM
AVEX.AI

This new asset class provides exposure to opportunities in blockchain, free of the risks associated with previous token offerings. Coming soon to the the SIX Swiss Stock Exchange.

FOR PATIENTS AND INNOVATORS
BIOSPHERES

This innovation marketplace connects patients and the global community directly with scientific innovators and experts from all over the world to address various stages of the innovation life cycle.

BLOCKCHAIN TOOLS
AVEX Token & The Aevolve Protocol

Cutting-edge medical science meets blockchain-driven technology to create new opportunities to drive innovation.